Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4451)
All Articles published online
|
Feb 15, 2012 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kanwar SS, Poolla A, Majumdar AP. Regulation of colon cancer recurrence and development of therapeutic strategies. World J Gastrointest Pathophysiol 2012; 3(1): 1-9 [PMID: 22368781 DOI: 10.4291/wjgp.v3.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v3/i1/1.htm |
| Number | Citing Articles |
| 1 |
William Tzu-Liang Chen, Tsia-Sheng Yang, Hung-Chang Chen, Hong-Hwa Chen, Hua-Che Chiang, Tsang-Chi Lin, Chung-Hung Yeh, Tao-Wei Ke, Jen-Shi Chen, Koung-Hung Hsiao, Min-Liang Kuo. Effectiveness of a novel herbal agent MB-6 as a potential adjunct to 5-fluoracil–based chemotherapy in colorectal cancer. Nutrition Research 2014; 34(7): 585 doi: 10.1016/j.nutres.2014.06.010
|
| 2 |
Janet Yuen Ha Wong, Judy Wai Chu Ho, Antoinette Marie Lee, Daniel Yee Tak Fong, Natural Chu, Sharron Leung, Y Y Wynnie Chan, Sharon HS Lam, Ivy P F Leung, Duncan Macfarlane, Ester Cerin, Aliki J Taylor, Kar Keung Cheng. Lived experience of dietary change among Chinese colorectal cancer survivors in Hong Kong: A qualitative study. BMJ Open 2021; 11(8): e051052 doi: 10.1136/bmjopen-2021-051052
|
| 3 |
Christopher Lieu, Erin B. Kennedy, Nancy Baxter. Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline Summary. Journal of Oncology Practice 2019; 15(7): 391 doi: 10.1200/JOP.19.00094
|
| 4 |
Huixia Li, Chuan Cheng, Weibo You, Jiujian Zheng, Jie Xu, Peng Gao, Jianping Wang, Tatsuya Toyokawa. TMEM100 Modulates TGF-β Signaling Pathway to Inhibit Colorectal Cancer Progression. Gastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/5552324
|
| 5 |
Pornsuda Maraming, Sompong Klaynongsruang, Patcharee Boonsiri, Surachai Maijaroen, Sakda Daduang, Jing‐Gung Chung, Jureerut Daduang. Antitumor activity of RT2 peptide derived from crocodile leukocyte peptide on human colon cancer xenografts in nude mice. Environmental Toxicology 2018; 33(9): 972 doi: 10.1002/tox.22584
|
| 6 |
So-Yeon Park, Ji-Young Kim, Jang-Hyun Choi, Jee-Heun Kim, Choong-Jae Lee, Pomila Singh, Shubhashish Sarkar, Jeong-Heum Baek, Jeong-Seok Nam. Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness. Clinical Cancer Research 2019; 25(4): 1415 doi: 10.1158/1078-0432.CCR-18-1232
|
| 7 |
Homood M. As Sobeai, Munirah Alohaydib, Ali R. Alhoshani, Khalid Alhazzani, Mashal M. Almutairi, Tareq Saleh, David A. Gewirtz, Moureq R. Alotiabi. Sorafenib, rapamycin, and venetoclax attenuate doxorubicin-induced senescence and promote apoptosis in HCT116 cells. Saudi Pharmaceutical Journal 2022; 30(1): 91 doi: 10.1016/j.jsps.2021.12.004
|
| 8 |
Guoce Cui, HongLi Zhao, Lina Li. Long noncoding RNA PRKCQ‐AS1 promotes CRC cell proliferation and migration via modulating miR‐1287‐5p/YBX1 axis. Journal of Cellular Biochemistry 2020; 121(10): 4166 doi: 10.1002/jcb.29712
|
| 9 |
Hana Janouskova, Anne-Marie Ray, Fanny Noulet, Isabelle Lelong-Rebel, Laurence Choulier, Florence Schaffner, Maxime Lehmann, Sophie Martin, Jan Teisinger, Monique Dontenwill. Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells. Cancer Letters 2013; 336(2): 307 doi: 10.1016/j.canlet.2013.03.018
|
| 10 |
Ashley C. Holmes, Anders H. Riis, Rune Erichsen, Veronika Fedirko, Eva Bjerre Ostenfeld, Mogens Vyberg, Ole Thorlacius-Ussing, Timothy L. Lash. Descriptive characteristics of colon and rectal cancer recurrence in a Danish population-based study. Acta Oncologica 2017; 56(8): 1111 doi: 10.1080/0284186X.2017.1304650
|
| 11 |
Mahdi Rivandi, Alireza Pasdar, Leila Hamzezadeh, Amir Tajbakhsh, Sima Seifi, Mehrdad Moetamani‐Ahmadi, Gordon A. Ferns, Amir Avan. The prognostic and therapeutic values of long noncoding RNA PANDAR in colorectal cancer. Journal of Cellular Physiology 2019; 234(2): 1230 doi: 10.1002/jcp.27136
|
| 12 |
Sarah Wedden, Keith Miller, Ian M. Frayling, Teresa Thomas, Alina Chefani, Karolina Miller, Angela Hamblin, Jenny C. Taylor, Corrado D’Arrigo. Colorectal Cancer Stratification in the Routine Clinical Pathway: A District General Hospital Experience. Applied Immunohistochemistry & Molecular Morphology 2019; 27(6): e54 doi: 10.1097/PAI.0000000000000631
|
| 13 |
Tao Cheng, Xiyuan Zhu, Jiying Lu, Xianglong Teng. MiR-532–3p suppresses cell proliferation, migration and invasion of colon adenocarcinoma via targeting FJX1. Pathology - Research and Practice 2022; 232: 153835 doi: 10.1016/j.prp.2022.153835
|
| 14 |
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal, Ankur Vaidya. Nanotechnology Applications for Cancer Chemotherapy. 2021; : 373 doi: 10.1016/B978-0-12-817846-1.00018-7
|
| 15 |
Shao-Jun Liu, Zhao-Qi Li, Xiao-Yan Wang, Fen Liu, Zhi-Ming Xiao, De-Cai Zhang. lncRNA UCA1 induced by SP1 and SP3 forms a positive feedback loop to facilitate malignant phenotypes of colorectal cancer via targeting miR-495. Life Sciences 2021; 277: 119569 doi: 10.1016/j.lfs.2021.119569
|
| 16 |
BOKYUNG SUNG, YONG JUNG KANG, DONG HWAN KIM, SEONG YEON HWANG, YUJIN LEE, MINJEONG KIM, JEONG-HYUN YOON, CHEOL MIN KIM, HAE YOUNG CHUNG, NAM DEUK KIM. Corosolic acid induces apoptotic cell death in HCT116 human colon cancer cells through a caspase-dependent pathway. International Journal of Molecular Medicine 2014; 33(4): 943 doi: 10.3892/ijmm.2014.1639
|
| 17 |
Christopher Lieu, Erin B. Kennedy, Emily Bergsland, Jordan Berlin, Thomas J. George, Sharlene Gill, Philip J. Gold, Alex Hantel, Lee Jones, Najjia Mahmoud, Jeffrey Meyerhardt, Arden M. Morris, Erika Ruíz-García, Y. Nancy You, Nancy Baxter. Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline. Journal of Clinical Oncology 2019; 37(16): 1436 doi: 10.1200/JCO.19.00281
|
| 18 |
Jennifer L. Meitzler, Mariam M. Konaté, James H. Doroshow. Hydrogen peroxide-producing NADPH oxidases and the promotion of migratory phenotypes in cancer. Archives of Biochemistry and Biophysics 2019; 675: 108076 doi: 10.1016/j.abb.2019.108076
|
| 19 |
Laurent Corcos, Catherine Le Jossic-Corcos. Statins: Perspectives in cancer therapeutics. Digestive and Liver Disease 2013; 45(10): 795 doi: 10.1016/j.dld.2013.02.002
|
| 20 |
Mahdi Abbasian, Elham Mousavi, Zahra Arab‐Bafrani, Amirhossein Sahebkar. The most reliable surface marker for the identification of colorectal cancer stem‐like cells: A systematic review and meta‐analysis. Journal of Cellular Physiology 2019; 234(6): 8192 doi: 10.1002/jcp.27619
|
| 21 |
Rashidah Baharudin, Nurul-Syakima Ab Mutalib, Sri N. Othman, Ismail Sagap, Isa M. Rose, Norfilza Mohd Mokhtar, Rahman Jamal. Identification of Predictive DNA Methylation Biomarkers for Chemotherapy Response in Colorectal Cancer. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00047
|
| 22 |
Wioletta Rozpędek, Dariusz Pytel, Adam Wawrzynkiewicz, Natalia Siwecka, Adam Dziki, Łukasz Dziki, J. Alan Diehl, Ireneusz Majsterek. Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer. Current Cancer Drug Targets 2020; 20(3): 223 doi: 10.2174/1568009620666200106114826
|
| 23 |
LEA RATH-WOLFSON, MICHAEL BERGMAN, YAACOV ORI, ALEX GOLDMAN, EDWARD RAM, RUMELIA KOREN, HERTZEL SALMAN. Expression of cyclin E in stage III colorectal carcinoma. Oncology Letters 2013; 5(1): 145 doi: 10.3892/ol.2012.955
|
| 24 |
Ji Won Choi, Jisun Lee, Seong Cheol Kim, SangGuan You, Chang Won Lee, Juhee Shin, Yong Il Park. Glucuronorhamnoxylan from Capsosiphon fulvescens inhibits the growth of HT-29 human colon cancer cells in vitro and in vivo via induction of apoptotic cell death. International Journal of Biological Macromolecules 2019; 124: 1060 doi: 10.1016/j.ijbiomac.2018.12.001
|
| 25 |
Xudong Zhang, Jinqiang Wang, Zhaowei Chen, Quanyin Hu, Chao Wang, Junjie Yan, Gianpietro Dotti, Peng Huang, Zhen Gu. Engineering PD-1-Presenting Platelets for Cancer Immunotherapy. Nano Letters 2018; 18(9): 5716 doi: 10.1021/acs.nanolett.8b02321
|
| 26 |
Nadiah Abu, Norahayu Othman, Kha W Hon, Wan FWM Nazarie, Rahman Jamal. Integrative meta-analysis for the identification of hub genes in chemoresistant colorectal cancer. Biomarkers in Medicine 2020; 14(7): 525 doi: 10.2217/bmm-2019-0241
|
| 27 |
Young‐Heon Kim, Seung Bum Lee, Sehwan Shim, Areumnuri Kim, Ji‐Hye Park, Won‐Suk Jang, Sun‐Joo Lee, Jae Kyung Myung, Sunhoo Park, Su‐Jae Lee, Min‐Jung Kim. Hyaluronic acid synthase 2 promotes malignant phenotypes of colorectal cancer cells through transforming growth factor beta signaling. Cancer Science 2019; 110(7): 2226 doi: 10.1111/cas.14070
|
| 28 |
Jing‑Ming Zhai, Yan‑Hui An, Wei Wang, Yong‑Gang Fan, Guo‑Liang Yao. IL‑32 expression indicates unfavorable prognosis in patients with colon cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10136
|
| 29 |
Estefania Martino-Echarri, Beric R. Henderson, Mariana G. Brocardo. Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapy. Oncotarget 2014; 5(20): 9889 doi: 10.18632/oncotarget.2475
|
| 30 |
Mohammad Yasin Zamanian, Maryam Golmohammadi, Bekhzod Abdullaev, María Olalla García, Adeeb Abdulally Abdulhussien Alazbjee, Abhinav Kumar, Sameer S. Mohaamed, Beneen M. Hussien, Fattaneh Khalaj, Seyede Mahsa Hodaei, Niyousha Shirsalimi, Gervason Moriasi. A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes. Cell Biochemistry and Function 2024; 42(3) doi: 10.1002/cbf.4011
|
| 31 |
Liyun Ji, Zeyuan Wang, Yin Ji, Huiyu Wang, Miao Guo, Lu Zhang, Peng Wang, Hua Xiao. Proteomics and phosphoproteomics analysis of tissues for the reoccurrence prediction of colorectal cancer. Expert Review of Proteomics 2022; 19(4-6): 263 doi: 10.1080/14789450.2022.2142566
|
| 32 |
Xu Wang, Shixin Chan, Jiajie Chen, Yuanmin Xu, Longfei Dai, Qijun Han, Zhenglin Wang, Xiaomin Zuo, Yang Yang, Hu Zhao, Ming Wang, Chen Wang, Zichen Li, Huabing Zhang, Wei Chen. Robust machine−learning based prognostic index using cytotoxic T lymphocyte evasion genes highlights potential therapeutic targets in colorectal cancer. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03239-y
|
| 33 |
Cheng Qian, Yongsheng Xia, Yun Ren, Yan Yin, Anmei Deng. Identification and validation of PSAT1 as a potential prognostic factor for predicting clinical outcomes in patients with colorectal carcinoma. Oncology Letters 2017; doi: 10.3892/ol.2017.7211
|
| 34 |
Riya Gupta, Lokesh Kumar Bhatt, Munira Momin. Potent antitumor activity of Laccaic acid and Phenethyl isothiocyanate combination in colorectal cancer via dual inhibition of DNA methyltransferase-1 and Histone deacetylase-1. Toxicology and Applied Pharmacology 2019; 377: 114631 doi: 10.1016/j.taap.2019.114631
|
| 35 |
Yan-Jiun Huang, Vijesh Kumar Yadav, Prateeti Srivastava, Alexander TH Wu, Thanh-Tuan Huynh, Po-Li Wei, Chi-Ying F. Huang, Tse-Hung Huang. Antrodia cinnamomea Enhances Chemo-Sensitivity of 5-FU and Suppresses Colon Tumorigenesis and Cancer Stemness via Up-Regulation of Tumor Suppressor miR-142-3p. Biomolecules 2019; 9(8): 306 doi: 10.3390/biom9080306
|
| 36 |
Murat Bardakci, Derya Demirtas Esmer, Emre Hafizoglu, Sendag Yaslikaya, Tugrul Burak Genc, Melike Ozcelik, Efe Cem Erdat, Engin Hendem, Mehmet Emin Buyukbayram, Zeynep Alaca Topcu, Ziya Kalkan, Nilgun Yildirim, Abdussamet Celebi, Yakup Ergun, Semra Paydas, Ali Murat Tatli, Hilal Karakas, Tolga Koseci, Mehmet Ali Nahit Sendur. Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated Surgically. Oncology 2023; 101(11): 723 doi: 10.1159/000531722
|